RADIATION THERAPY ONCOLOGY GROUP
RTOG 1205
RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VERSUS BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA
RTOG 1205
RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VERSUS BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA
Protocol Participation Information
- Credentialing Requirements
- Facility Questionnaire: Part I and Part II are required for this protocol.
- Download fillable forms and complete them.
- Submit to RTOG RT Quality Assurance Department
Email: [email protected] Fax: 215-940-8817
- IGRT Immobilization/Localization Systems Test
- Submitting 1205 IGRT Data to the ITC - please contact Bill Straube at 314-362-9762 for questions
- Anonymized Patient Spreadsheet to be submitted with the Anonymized IGRT credentialing data, and the first registered patient's IGRT case data. See Section 5.0 of the Protocol. (updated 6/27/2011)
- RPC Phantom Dosimetry Test (IMRT only)
- Fill out the RPC Phantom Request Form to request shipment of a phantom.
- Phantom irradiation guidelines and forms (contact RPC at 713-745-8989 with questions)
- Contact Bill Straube at 314-362-9762 regarding submission of phantom treatment planning data to the ITC.
- ITC Digital Data Submission Test
- Contact Bill Straube at 314-362-9762 for instructions.
- Facility Questionnaire: Part I and Part II are required for this protocol.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Data Submission Check list
- ATC Compliant Treatment Planning Systems
- Structure Names - Please refer to protocol text for structure naming requirements.
- Study Details Page (http://www.rtog.org/)
Back to protocols
